RxDoctor Payments Data

Megan Williams, DO

Family Medicine · Winchester, VANPI 1699938829

Payments from drug & device makers

$657in general payments, 2019–2025

Across 32 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$122
  • Amgen$92
  • Boehringer Ingelheim$89
  • Pfizer$82
  • Johnson & Johnson$72
  • Lilly USA, LLC$67
  • plus $133 from 5 others

What the payments were for

  • Food & beverage$63196%
  • Education$264%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$657 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$182,807
Medicare patients
586
Services billed
2,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban88$93,295
JardianceEmpagliflozin59$85,247
TrulicityDulaglutide47$77,962
OzempicSemaglutide40$75,476
Tresiba Flextouch U-200Insulin Degludec34$41,668
MounjaroTirzepatide15$30,852
FarxigaDapagliflozin Propanediol23$24,143
Tresiba Flextouch U-100Insulin Degludec21$19,445
XareltoRivaroxaban18$17,162
SymbicortBudesonide/Formoterol Fumarate17$10,483
JanumetSitagliptin Phos/Metformin Hcl12$6,738
SynthroidLevothyroxine Sodium47$3,638
Atorvastatin Calcium545$3,562
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$3,105
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro17$2,075

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$67$108,81462 claims
PfizerEliquis$82$93,29588 claims
Boehringer IngelheimJardiance$89$85,24759 claims
Novo NordiskOzempic$122$75,47640 claims
AstraZenecaFarxiga, Symbicort$15$34,62640 claims
Johnson & JohnsonXarelto$72$17,16218 claims
AbbVieSynthroid$60$3,63847 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Winchester

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →